Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-18-012099

Options or other derivatives

  • Controller/Prin Fin&Acct Offic acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Austin Mark John Controller/Prin Fin&Acct Offic 2018-06-13 Grant or award · Stock Options (right to buy) +100,000 175,000 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…